● Recruiting

WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

Condition: SCLC,Extensive Stage · Brain Metastases · Sponsor: Fudan University

PhasePhase 1/Phase 2

Planned participants56

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study aims to evaluate the safety and efficacy of hippocampal-sparing WBRT combined with SRS as first-line treatment for SCLC patients with brain metastases.

This description comes directly from the study's public registry record.

Talk to the study team

zhengfei zhu · +8618017312901 · fuscczzf@163.com

Xiao Chu · +8618017317922 · chuxiao@sibs.ac.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Fudan University Shanghai Cancer Center

Shanghai, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06243003